Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 279, Issue 5 42-5, 2000, Pages

  Persson, Kristin ^a   Gingerich, Ronald L ^b   Nayak, Sonali ^b   Wada, Keiji ^c   Wada, Etsuko ^c   Ahrén, Bo ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b Linco Research   (United States)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gastrin releasing peptide; Glucagon like peptide; Glucose tolerance; Insulin secretion; Knockout mice

Indexed keywords

GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE TARGETING; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STOMACH ABSORPTION;

EID: 0033662673     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.279.5.e956     Document Type: Article

References (41)

1. Glucagon-like peptide 1 (GLP-1) - A gut hormone of potential interest in the treatment of diabetes
2. Potentiators and inhibitors of insulin secretion
3. Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance
4. Molecular cloning of the bombesin/gastrin releasing peptide receptor from Swiss 3T3 cells
5. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization
6. Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides
7. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig
8. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: Studies with the antagonist exendin 9-39
9. Glucagon-like peptide 1 cells in the gastrointestinal tract and pancreas of rat, pig, and man
10. A novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells
11. Studies on the mechanisms by which gastrin releasing peptide stimulates insulin secretion from mouse islets
12. Potential therapeutic levels of glucagon-like peptide-1 achieved in humans by a buccal tablet
13. The incretin concept and its relevance to diabetes
14. Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice
15. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV activity in the capillaries supplying the L-cells of the porcine intestine
16. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitter and peptides
17. Enteroglucagon
18. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes
19. Insulin secretion by gastrin-releasing peptide in mice: Ganglionic versus direct islet effect
20. Modulation of gastrin-releasing peptide (GRP) receptors in insulin secreting cells
21. Glucagon-like peptide-1 (9-36)amide is a major metabolite of glucagon-like peptide-1 (7-36)amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
22. Gastrin-releasing peptide in the porcine pancreas
23. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39)amide
24. Glucagon-like peptide-1 7-36: A physiological incretin in man
25. Comparative mapping of the Grpr locus on the X chromosomes of man and mouse
26. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue
27. Dipeptidyl-peptidase IV (CD26) - Role in the inactivation of regulatory peptides
28. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy
29. Neuronal gastrin-releasing peptide in the mammalian gut and pancreas
30. Gastrin-releasing peptide (GRP): Effects on basal and stimulated insulin and glucagon secretion in the mouse
31. Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut
32. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
33. Role of gastrin-releasing peptide in pepsinogen secretion from the isolated perfused rat stomach
34. Parasympathetic involvement in rapid meal-associated conditioned insulin secretion in the rat
35. Stimulation of gastrin release by bombesin and canine gastrin-releasing peptides. Studies with isolated canine G cells in primary culture
36. Stimulation of truncated glucagon-like peptide-1 release from the isolated perfused canine ileum by glucose absorption
37. Glucagon-like peptide-1 (GLP-1) secretion is decreased in type II diabetic patients compared to matched control subjects with normal glucose tolerance
38. Effect of GIP and GLP-1 antagonists on insulin release in the rat
39. Generation and characterization of mice lacking gastrin-releasing peptide receptor
40. cDNA cloning, characterization and brain region-specific expression of neuromedin B-preferring bombesin receptor
41. Glucagon-like peptide-1 (7-36)amide's inhibitory effect on antral motility is antagonised by its N-terminally truncated primary metabolite GLP-1 (9-36)amide